Debate โ€บ Science ยท Last reviewed 2026-05-16

Scientific criticism

Summary

Scientific criticism of the Dutch Protocol clusters around four points: (i) the absence of randomised or controlled studies, (ii) selective attrition and small sample sizes, (iii) limited follow-up duration and (iv) a population shift between the original cohorts and contemporary referral patterns. The Cass Review (2024) summarises this criticism and uses it as a basis for its own recommendations. See also /studies/methodological-criticism/.

1. Central points

  • No RCTs; only observational cohort studies โ€” see /studies/replication-attempts/.
  • Small sample sizes (n=55 in de Vries 2014) โ€” see /studies/sample-size-and-attrition/.
  • Short follow-up (1 year post-operatively) โ€” see /protocol/follow-up/.
  • Changed population: in the Amsterdam cohort the ratio of referrals shifted over time toward people assigned female at birth (van der Loos 2023, source); whether the current group otherwise differs from the earlier one is disputed โ€” the Cass Review says the approach was extended to a broader group (source), while Arnoldussen e.a. (2020) found, among 1,072 adolescents referred between 2000 and 2016, no trend in the intensity of gender dysphoria apart from the shift toward birth-registered girls (source).
  • Outcome measures heterogeneous between studies.

2. Response from the original team

In the Zembla broadcast of 26 October 2023, in which methodologists rated the evidence as scientifically insufficient (professor of methodology Gerard van Breukelen), Annelou de Vries (Amsterdam UMC) said that research with a control group "is not an option, because you would be withholding a treatment that you know is extremely important for a group" (translated from Dutch; source). See /debate/response-vumc-amsterdam-umc/.

3. Dutch critical voices

Within the Netherlands, the Health Council advised on 30 June 2026 that the due-care requirements should be strengthened in the revision of the Quality Standard Transgender Care โ€” Somatic, while seeing no reason to organise the care differently (source); critical commentary has come from, among others, law professor Lodewijk Smeehuijzen (NJB) and medical ethicist Jilles Smids (NTvG). A recurring point in these commentaries is that the Quality Standard Transgender Care (2017โ€“2018) rests on the assumption that gender dysphoria in young people causes mental problems and that medical intervention reduces these problems โ€” a causal assumption that, according to critics, has not been prospectively tested.1

The same commentary refers to a Finnish register study by Ruuska et al., published in Acta Paediatrica in 2026 (source), which found that among adolescents who underwent medical gender reassignment severe psychiatric morbidity rose during follow-up (from 9.8% to 60.7% after feminising and from 21.6% to 54.5% after masculinising treatment); the authors conclude that psychiatric needs do not subside after medical reassignment. The study is observational, and critiques of it have been published in the same journal, to which the authors have responded. The authors of the Substack analysis Genderzorgen (10 April 2026) conclude that routine medical treatment outside research settings is ethically hard to defend, and refer to critical statements by clinical psychologist Dorine Sellenraad (VUmc gender clinic 2000-2001, in the 2018 Zembla broadcast "Transgender met spijt"); according to the post, the authors sent their analysis to the Minister of Health, Welfare and Sport and to the standing committee on health of the House of Representatives (source).2

Status of sources: the Substack publication is not peer-reviewed scientific literature and is โ€” in line with the editorial methodology โ€” cited as public commentary, not as a factual source. The underlying register study by Ruuska et al. has since been published peer-reviewed in Acta Paediatrica (2026).

See also

Footnotes

  1. Federation of Medical Specialists. Quality Standard Transgender Care โ€” Somatic. 2018 (translation by editors).
  2. Genderzorgen. Transgender care under scrutiny: an untested assumption as treatment protocol. Substack, 10 April 2026 (translation by editors). https://genderzorgen.substack.com/p/transgenderzorg-onder-de-loep